Fitxa persona

Ángeles Álvarez Ribelles is a Full Professor of Pharmacology at the Universitat de València (UV) since 2023.

She graduated in Pharmacy (1997) and completed a PhD in Pharmacy (2002) at the UV. Her doctoral thesis “Proinflammatory action of Angiotensin II”, was awarded the UV’s Year’s Best Thesis Prize. On completing her PhD, Angeles began her postdoctoral training in the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in 2003, participating in a project awarded the IV Salvat Laboratories Prize for the best health sciences research project by the Salvat Inquifarma Foundation. She continued her postdoctoral training at Harvard Medical School - the fifth best university in the world - studying the spatial and temporal location of integrins during the process of leukocyte migration. Both research stays were financed by scholarships obtained from the Ministry of Health and the Ministry of Education, respectively.

In 2006, she joined the Department of Pharmacology at the UV as a Researcher sponsored by the Spanish Ministry of Education and Science’s Ramon y Cajal Program. She has been a member of CIBERehd (CB06/04/0071), a national network of research groups investigating digestive and hepatic diseases, since its foundation in 2007, and is a member of a PROMETEO research group of excellence funded by the regional government’s PROMETEO program. In recent years her research has focused on the study of the cellular and molecular mechanisms involved in the vascular toxicity induced by antiretroviral therapy. 

She has been principal investigator of 14 publicly funded research projects, 5 of them within the Spanish central government’s “Plan Nacional” research program (SAF2007, 60021, SAF2010-16030, SAF2015-67678-R, RTI2018-094436-B-I00, PID2022-137678OB-I00). In addition, she has received 9 grants from the Valencian regional government and CIBERehd, amongst other institutions. She has also led, as principal investigator, 5 translational studies about antiretroviral drugs in collaboration with the pharmaceutical industry. She possesses 4 research sexennials (2000-2005, 2006-2011, 2012-2017, 2018-2023) and 1 transfer of scientific knowledge sexennial (2013-2018). The results obtained by the group led by Dr. Alvarez have been published in specialist journals in the fields of Pharmacology – such as British Journal of Pharmacology - and of Infectious Diseases - such as AIDS, Journal of Infectious Diseases and Journal of Antimicrobial Chemotherapy, most of which are in the first decile of their category.
To date, Dr. Alvarez has published 56 original articles (h index=26, total number of citations= 2.415 on 01/09/2025) in international journals with a high impact factor, such as Circulation, Circulation Research, Blood and British Journal of Pharmacology, of which 49 are in the first quartile and 20 are in the first decile of their specialist field, having a relevant position in 25. In addition, she has presented more than 100 communications in congresses. She has directed 8 doctoral theses, 12 master’s theses and 28 undergraduate dissertations. She has supported the successful application of 5 pre-doctoral research contracts funded by calls of the regional or central governments and 1 Ramón y Cajal researcher contract.